AIM
KALA icon

Alambic Investment Management’s KALA BIO KALA Stock Holding History

Alambic Investment Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4
Closed -$40K – 232
2019
Q4 		$40K Sell
4
-3
-43% -$29K 0.03% 275
2019
Q3 		$65K Sell
7
-28
-80% -$341K 0.05% 279
2019
Q2 		$552K Buy
35
+18
+106% +$298K 0.34% 116
2019
Q1 		$344K Buy
+17
New +$302K 0.14% 211

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alambic Investment Management's KALA Position: Q1 2020 in Review

Alambic Investment Management sold out of KALA BIO (KALA) in Q1 2020, closing a stake of 4 shares — an estimated $40K sold.

Alambic Investment Management first reported a position in KALA in Q1 2019 and held it in 4 quarters. The position peaked at $552K in Q2 2019. 83 funds tracked by Wall St. Rank hold KALA as of Q1 2020.

  • Alambic Investment Management reported no remaining KALA BIO position as of Q1 2020 after selling out during the quarter.
  • Alambic Investment Management sold 4 KALA BIO shares in Q1 2020, an estimated $40K.
  • Alambic Investment Management first reported a position in KALA BIO in Q1 2019 and held it in 4 quarters.
  • Alambic Investment Management's KALA BIO position peaked at $552K in Q2 2019.
  • 83 funds tracked by Wall St. Rank held KALA BIO as of Q1 2020.

Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.